Post-Ablation Pericarditis Reduction Study
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 248 participants.
Also called NCT04906720
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 248 participants
- Registry
-
NCT04906720
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04906720. Randomized; no masking; primary purpose prevention. Start 2021-05-20 (actual); primary completion 2022-01-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Post-Ablation Pericarditis Reduction Study
- Acronym
- PAPERS
- Condition
- Atrial Fibrillation
- Condition
- Catheter Ablation
- Condition
- Pericarditis
- Intervention (Drug)
- Colchicine
- Lead sponsor
- St. Vincent Cardiovascular Research Institute
Record details
- Record id
cardio:ct-nct04906720- Content hash
8ea6a16953804e7aeb6c0f742fa2ae45b362bfb24701e845a0ed39ebda089cb0